HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis.

AbstractBACKGROUND:
Idiopathic cerebral vein thrombosis (iCVT) represents approximately 30% of the cases of cerebral vein thrombosis (CVT). New, inherited - factor V Leiden (FVL) and prothrombin gene mutation (PTHRA20210) - and inherited/acquired - hyperhomocysteinemia (HHcy) - prothrombotic conditions have been detected recently.
METHODS:
We assessed fasting plasma homocysteine (Hcy) levels and main Hcy determinants, FVL and PTHRA(20210) in 30 patients with documented iCVT and 40 age- and sex-matched healthy subjects.
RESULTS:
A strong and significant association of PTHRA(20210) [30% (9/30) vs. 2.5% (1/40) iCVT vs. controls, respectively, p = 0.001; OR = 16.174, p = 0.002] and HHcy [13/30 (43.3%) vs. 4/40 (10%) iCVT vs. controls, respectively; p = 0.002, OR = 6.88, p = 0.002] with iCVT was found.
CONCLUSIONS:
PTHRA(20210) and HHcy should be considered when screening for thrombophilia and should be assessed in patients with a family or personal history of CVT.
AuthorsPaolo Ventura, Milena Cobelli, Marco Marietta, Rossana Panini, Maria Cristina Rosa, Gianfranco Salvioli
JournalCerebrovascular diseases (Basel, Switzerland) (Cerebrovasc Dis) Vol. 17 Issue 2-3 Pg. 153-9 ( 2004) ISSN: 1015-9770 [Print] Switzerland
PMID14707415 (Publication Type: Journal Article)
CopyrightCopyright 2004 S. Karger AG, Basel
Chemical References
  • Protein C
  • Protein S
  • factor V Leiden
  • Homocysteine
  • Antithrombin III
  • Factor V
  • Prothrombin
Topics
  • Adult
  • Antithrombin III (metabolism)
  • Cerebral Veins
  • Factor V (genetics)
  • Female
  • Homocysteine (blood)
  • Humans
  • Hyperhomocysteinemia (epidemiology, genetics)
  • Intracranial Thrombosis (epidemiology, genetics)
  • Male
  • Point Mutation
  • Prevalence
  • Protein C (metabolism)
  • Protein S (metabolism)
  • Prothrombin (genetics)
  • Risk Factors
  • Thrombophilia (epidemiology, genetics)
  • Venous Thrombosis (epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: